Natural Modulators of Large-Conductance Calcium-Activated Potassium Channels

Planta Medica

Volumn 69, Issue 10, 2003, Pages 885-892

  Nardi, Antonio ^a   Calderone, Vincenzo ^a   Chericoni, Silvio ^a   Morelli, Ivano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

BK activators; BK blockers; Large conductance calcium activated BK channels; Natural products; Potassium channels

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; 1 (5 CHLORO 2 HYDROXYPHENYL) 5 TRIFLUOROMETHYL 2 BENZIMIDAZOLONE; ALKALOID DERIVATIVE; APIGENIN; CAF 603; CALCIUM ACTIVATED POTASSIUM CHANNEL; CGS 7184; CHARYBDOTOXIN; FLAVANOID; HESPERETIN; IBERIOTOXIN; KAEMPFEROL; L 735334; LUTEOLIN; MAGNOLOL; NARINGENIN; NORDIHYDROGUAIARETIC ACID; NS 1608; PASPALICINE; PAXILLINE; PHENOL DERIVATIVE; PHLORETIN; POTASSIUM CHANNEL AFFECTING AGENT; PRIMULETIN; QUINIDINE; QUININE; RESVERATROL; TERPENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERRUCULOGEN; VINPOCETINE;

CALCIUM CONDUCTANCE; CELL FUNCTION; CHANNEL GATING; DRUG DESIGN; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; EXCITABILITY; PATCH CLAMP; REVIEW; STRUCTURE ACTIVITY RELATION;

BENZIMIDAZOLES; CHLOROPHENOLS; HUMANS; PHYTOTHERAPY; PLANTS, MEDICINAL; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED;

CINCHONA PUBESCENS;

EID: 0347477308     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-45095     Document Type: Review

References (69)

1. Calderone V. Large-conductance calcium-activated potassium channels: function, pharmacology and drugs. Curr Med Chem 2002; 9: 1385-95
2. Garcia-Calvo M, Knaus H-G, McManus OB, Giangiacomo KM, Kaczorowski GJ, Garcia ML. Purification and reconstitution of the high-conductance, calcium-activated potassium channel from tracheal smooth muscle. J Biol Chem 1994; 269: 676-82
3. Dworetzky SI, Boissard CG, Lum-Ragan JT, McKay MC, Post-Munson DJ, Trojnacki JT, Chang CP, Gribkoff VK. Phenotypic alteration of a human BK (hSlo) channel by hSlobeta subunit coexpression: changes in blocker sensitivity, activation/relaxation and inactivation kinetics, and protein kinase A modulation. J Neurosci 1996; 16: 4543-50
4. Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 2001; 81: 1415-59
5. + channels: physiological role and pharmacology. Curr Med Chem 2003; 10: 649-61
6. 2+ sensitivity-regulating β subunit. FASEB J 2000; 14: 885-94
7. Ca, channels mediate flow-dependent dilation of arterioles of skeletal muscle and mesentery. Microvasc Res 2001; 61: 179-86
8. Gribkoff VK, Starrett JE Jr, Dworetzky SI. The pharmacology and molecular biology of large-conductance calcium-activated (BK) potassium channels. Adv Pharmacol 1997; 37: 319-48
9. Robitaille R, Garcia ML, Kaczorowski GJ, Charlton MP. Functional colocalization of calcium and calcium-gated potassium channels in control of transmitter release. Neuron 1993; 11: 645-55
10. 2+ domains in Helix neurons. Neuron 1993; 10: 689-99
11. Volk KA, Matsuda JJ, Shibata EF. A voltage-dependent potassium current in rabbit coronary artery smooth muscle cells. J Physiol (Lond) 1991; 439: 751-68
12. Ca channels by PKA in pregnant and nonpregnant myometrium. Am J Physiol 1994; 266: C1459-63
13. Ca, channels in the muscarinic and beta-adrenergic regulation of airway smooth muscle. Am J Physiol 1995; 268: L221-9
14. Vogalis F. Potassium channels in gastrointestinal smooth muscle. J Auton Pharmacol 2000; 20: 207-19
15. Tanaka Y, Horinouchi T, Tanaka H, Shigenobu K, Koike K. BK channels play an important role as a negative feedback mechanism in the regulation of spontaneous rhythmic contraction of urinary bladder smooth muscles. Nippon Yakurigaku Zasshi 2002; 120: 106P-8
16. Pelaia G, Gallelli L, Vatrella A, Grembiale RD, Maselli R, De Sarro GB, Marsico SA. Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease. Life Sci 2002; 70: 977-90
17. Hewawasam P, Erway M, Thalody G, Weiner H, Boissard CG, Gribkoff VK, Meanwell NA, Lodge N, Starrett JE Jr. The synthesis and structureactivity relationships of 1,3-diaryl 1,2,4-(4H)-triazol-5-ones: a new class of calcium-dependent, large conductance, potassium (maxi-K) channel opener targeted for urge urinary incontinence. Bioorg Med Chem Lett 2002; 12: 1117-20
18. Starrett JE Jr, Dworetsky SI, Gribkoff VK. Modulators of large-conductance calcium-activated potassium (BK) channels as potential therapeutic targets. Curr Pharm Des 1996; 2: 413-28
19. Berger MG, Rusch NJ. Voltage and calcium-gated potassium channels: functional expression and therapeutic potential in the vasculature. Perspec Drug Disc Des 1999; 15/16: 313-32
20. (+) channels as therapeutic drug targets. Pharmacol Ther 2002; 94: 157-82
21. Rundfeldt C. Potassium channels and neurodegenerative diseases. Drug News Perspect 1999; 12: 99-104
22. Gribkoff VK, Starrett JE Jr, Dworetsky SI. Maxi-K potassium channels: form, function and modulation of a class of endogenous regulators of intracellular calcium. Neuroscientist 2001; 7: 166-77
23. Hewawasam P, Fan W, Knipe J, Moon SL, Boissard CG, Gribkoff VK, Starrett JE Jr. The synthesis and structure-activity relationships of 4-aryl-3-aminoquinolin-2-ones: a new class of calcium-dependent, large conductance, potassium (maxi-K) channel openers targeted for post-stroke neuroprotection. Bioorg Med Chem Lett 2002; 12: 1779-83
24. Archer SL. Potassium channels and erectile dysfunction. Vasc Pharmacol 2002; 38: 61-71
25. Olesen S-P, Watjen F. Benzimidazole derivatives, their preparation and use. European Patent Application, EP 0477819, 1992
26. + channels by novel benzimidazolone. Eur J Pharmacol 1994; 251: 53-9
27. McManus OB, Harris GH, Giangiacomo KM, Feigenbaum P, Reuben JP, Addy ME, Burka JF, Kaczorowski GJ, Garcia ML. An activator of calcium-dependent potassium channels isolated from a medicinal herb. Biochemistry 1993; 32: 6128-33
28. Giangiacomo KM, Kamassah A, Harris G, McManus OB. Mechanism of Maxi-K channel activation by dehidrosoyasaponin-1. J Gen Physiol 1998; 112: 485-501
29. Singh SB, Goetz MA, Zink DL, Dombrowski AW, Polishook JD, Garcia ML, Schmalhofer W, McManus OB, Kaczorowski GJ. Maxikdiol: a novel dihydroxyisoprimane as an agonist of maxi-K channels. J Chem Soc Perkin Trans 1994; 1: 3349-52
30. + channel α-subunit. Mol Pharmacol 2002; 62: 836-46
31. Ondeyka JG, Ball RG, Garcia ML, Dombrowski AW, Sabnis G, Kaczorowski GJ, Zink DL, Bills GF, Goetz MA, Schmalhofer WA, Singh SB. A carotane sesquiterpene as a potent modulator of the Maxi-K channel from Arthrinium phaesospermum. Bioorg Med Chem Lett 1995; 5: 733-4
32. Lee SH, Hensens OD, Helms GL, Liesch JM, Zink DL, Giacobbe RA, Bills GF, Stevens-Miles S, Garcia ML, Schmalhofer WA, McManus OB, Kaczorowski GJ. L-735,334, a novel sesquiterpenoid potassium channel-agonist from Trichoderma virens. J Nat Prod 1995; 58: 1822-8
33. Burns J, Yokota T, Ashihara H, Lean MEJ, Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem 2002; 50: 3337-40
34. + current in vascular endothelial cells. Cardiovasc Res 2000; 45: 1035-45
35. (Ca) channel in cultured smooth muscle cells of human trachea by magnolol. Thorax 2002; 57: 67-74
36. Lambert JD, Zhao D, Meyers RO, Kuester RK, Timmermann BN, Dorr RT. Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse. Toxicon 2002; 40: 1701-8
37. + channels by nordihydroguaiaretic acid in porcine coronary arterial smooth muscle cells. Jpn J Pharmacol 1996; 70: 281-4
38. + current by nordihydroguaiaretic acid in porcine coronary arterial smooth muscle cells. J Pharmacol Exp Ther 1999; 291: 140-6
39. + channels by nordihydroguaiaretic acid. Jpn J Pharmacol 2002; 89: 53-63
40. 2+-dependent large-conductance potassium channels: pharmacophore search and physiological evaluation of flavonoids. Bioorg Med Chem Lett 1997; 7: 759-62
41. Calderone V, Chericoni S, Testai L, Morelli I, Martinotti E. Role of potassium channels in the vasodilator response of flavonoids naringine and naringenine. IX Congress of the Italian Society of Pharmacognosy, Taormina (Messina, Italy): 26th October, 2001: P25
42. Calderone V, Testai L, Martinelli C, Chericoni S, Morelli I, Martinotti E. Role of BK potassium channel in the vasorelaxing effect of flavonoids. X Congress of the Italian Society of Pharmacognosy, S. Margherita di Pula (Cagliari, Italy): 2nd-6th October, 2002: P38
43. + channels in myelinated nerve fibers of Xenopus laevis. Neurosci Lett 1994; 165: 167-70
44. Kidd PM. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev 1999; 4: 144-61
45. Bonoczk P, Gulyas B, Adam-Vizi V, Nemes A, Karpati E, Kiss B, Kapas M, Szantay C, Koncz I, Zelles T, Vas A. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine. Brain Res Bull 2000; 53: 245-54
46. 3 cells. Biochem Pharmacol 2001; 61: 877-92
47. Coghlan MJ, Carroll WA, Gopalakrishnan M. Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress. J Med Chem 2001; 44: 1627-53
48. 2+-dependent large-conductance potassium channel: symmetrical pharmacophore and electrophysiological evaluation of bisphenols. Bioorg Med Chem Lett 2003; 13: 1437-9
49. Olesen S-P, Moldt P, Pedersen O. International Patent Application. 1994: WO 9422807
50. Hu S, Fink CA, Kim HS, Lappe RW. Novel and potent BK channel openers: CGS 7181 and its analogs. Drug Dev Res 1997; 41: 10-21
51. Legros C, Bougis PE, Martin-Eauclaire M-F. Molecular biology of scorpion toxins active on potassium channels. Perspect Drug Disc Des 1999; 15/16: 1-14
52. + channels from mammalian skeletal muscle. Nature 1985; 313: 316-8
53. + channels in human T lymphocytes. J Biol Chem 1992; 267: 8650-7
54. Giangiacomo KM, Garcia ML, McManus OB. Mechanism of iberiotoxin block of the large-conductance calcium-activated potassium channel from bovine aortic smooth muscle. Biochemistry 1992; 31: 6719-27
55. + channel. Biophys J 1992; 63: 583-90
56. Galvez A, Gimenez Gallego G, Reuben JP, Roy Contancin L, Feigenbaum P, Kaczowroski GJ, Garcia ML. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem 1990; 265: 11083-90
57. Garcia ML, Kaczorowski GJ. Pharmacology of high-conductance calcium-activated potassium channels. Curr Res Ion Channel Modul 1998; 3: 213-20
58. Garcia-Valdes J, Zamudio FZ, Toro L, Possani LD. Slotoxin, αKTx1.11, a new scorpion peptide blocker of MaxiK channels that differentiates between a and α+β (β1 or β4) complexes. FEBS Letters 2001; 505: 369-73
59. Wu Y, Wang Z-F, Shi Y-L. Beta-agkistrodotoxin inhibits large-conductance calcium-activated potassium channels in rat hippocampal CA1 pyramidal neurons. Brain Res 2002; 940: 21-6
60. Armando-Hardy M, Ellory JC, Ferreira HG, Fleminger S, Lew VL. Inhibition of the calcium-induced increase in the potassium permeability of human red blood cells by quinine. J Physiol 1975; 250: 32P-3
61. Burgess GM, Claret M, Jenkinson DH. Effects of quinine and apamin on the calcium-dependent potassium permeability of mammalian hepatocytes and red cells. J Physiol 1981; 317: 67-90
62. Cook NS. Potassium channels: structure, classification, function and therapeutic potential. Ellis Horwood Limited, Southampton: 1990
63. Knaus H-G, McManus OB, Lee SH, Schmalhofer WA, Garcia-Calvo M, Helms LM, Sanchez M, Giangiacomo K, Reuben JP, Smith AB III, Kaczorowski GJ and Garcia ML. Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry 1994; 33: 5819-28
64. Sanchez M, McManus OB. Paxilline inhibition of the alpha-subunit of the high-conductance calcium-activated potassium channel. Neuropharmacol 1996; 35: 963-8
65. + channel blockers paspalitrem-C and paxilline on mammalian smooth muscle. Eur J Pharmacol 1996; 314: 123-8
66. Wang ZG, Liu GZ. Advances in natural products in China. TIPS 1985; 6: 423-5
67. 2+ current in isolated nerve terminals of the rat neurohypophysis. Pflugers Arch 1992; 421: 558-65
68. Wu S-N, Li HF, Lo YC. Characterization of tetrandrine-induced inhibition of large-conductance calcium-activated potassium channels in a human endothelial cell line (HUV-EC-C). J Pharmacol Exp Ther 2000; 292: 188-95
69. + channels. Life Sci 1995; 56: 295-306